The 4th quarter edition of our ReMarks newsletter is out, including:

  • A "FRAND Injunction" – UK Courts develop a new remedy
  • Patent term extensions in Canada
  • Validation of European patents in Tunisia
  • Accelerated examination for cancer treatments at the USPTO
  • Changes to the Guidelines for Examination
  • Moz the Monster v Mr Underbed
  • Changes to the patent and registered designs regime in Singapore
  • The microbiome: a rapidly developing field with implications for health, disease and ageing
  • Actavis v Eli Lilly: Supreme Developments
  • Reduced UK design fees help ease Brexit uncertainty

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.